Company / Net Income
West Pharmaceutical Services Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$493.7M
FY2025
5-year range
$241.7M / $593.4M
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
#39 of 164
Health Care
What the data says
West Pharmaceutical Services's net income of $494M is higher than 76% of companies in the Health Care sector (FY2025). Net Income has fluctuated over the past 10 years, ranging from $127M in FY2016 to $593M in FY2023.
Based on SEC 10-K filings.
$494M in FY2025 with a 5-year CAGR of +19.0%. Top quartile in the Health Care sector.
Declined from $593M to $494M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +12.6%
- 5-Year CAGR
- +19.0%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 164This company $493.7M Sector average $467.2M
▼
+5.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +19.0%, indicating consistent growth.
- In FY2025, net income increased 0.2% year-over-year.
- Ranks #39 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $493.7M | +0.2% |
| FY2024 | $492.7M | -17.0% |
| FY2023 | $593.4M | +71.4% |
| FY2022 | $346.2M | +43.2% |
| FY2021 | $241.7M | +16.8% |
| FY2020 | $206.9M | -14.4% |
| FY2019 | $241.7M | +16.8% |
| FY2018 | $206.9M | +37.3% |
| FY2017 | $150.7M | +18.6% |
| FY2016 | $127.1M | +13.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026